Prognostic significance of neuroendocrine differentiation in prostate adenocarcinoma

L Sagnak, H Topaloglu, U Ozok, H Ersoy - Clinical genitourinary cancer, 2011 - Elsevier
Much progress has been made toward an understanding of the development and
progression of prostate cancer (PC) and the factors that drive the development of androgen …

[HTML][HTML] Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes

MC Topf, M Tuluc, LA Harshyne… - Journal for ImmunoTherapy …, 2017 - Springer
Background The tumor microenvironment often polarizes infiltrating macrophages towards a
type 2, or M2 phenotype, that is characterized by expression of various cysteine-rich …

[PDF][PDF] Metastatic prostate adenocarcinoma presenting with bilateral inguinal adenopathy

MA Tunio, A Hashami, SS Raza - J Surg Pak, 2011 - old.jsp.org.pk
Prostate adenocarcinoma accounts for approximately 3.4% of all the cancers and ranks 8th
in Pakistani males, 1 of whom 70% of patients are diagnosed as advanced metastatic …

[HTML][HTML] De novo purely prostatic large-cell neuroendocrine carcinoma with thyroid and adrenal metastases

E Karvounis, I Zoupas, D Bantouna… - … & Metabolism Case …, 2022 - edm.bioscientifica.com
Large-cell neuroendocrine carcinoma (LCNEC) is a rare neuroendocrine prostatic
malignancy. It usually arises after androgen deprivation therapy (ADT), while de novo cases …

[PDF][PDF] Prostate Cancer Presenting as Left Supraclavicular Lymphadenopathy and a Review of the Literature

H Jumastapha, S Ghauth - researchgate.net
Aims: Patients presenting with a neck mass are commonly seen by the ENT surgeon. They
are also usually related to head and neck tumours. However, cervical node involvement …